Riskpilot← Back to searchSign inGet full accessLILJEN AS
ASActiveOrg 989614940Hvedings Gate 4, 9405 HarstadMedical specialists activities · NACE 8622Est. 20061 employees
Revenue 2025
NOK 4,4M
-10% vs 2024
EBITDA margin
38.5%
+32% vs 2024
Equity ratio
80.1%
Financial strength
Net profit 2025
NOK 1,2M
+34% vs 2024
| Revenue | NOK 4,4M | -10% |
| EBITDA | NOK 1,7M | +32% |
| Net profit | NOK 1,2M | +34% |
| Total assets | NOK 5,2M | +28% |
| Equity | NOK 4,1M | +41% |
| Employees | 1 | — |
Legal name
LILJEN AS
Org number
989614940
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
25. mars 2006
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Medisinsk kosmetisk behandling, samt hva hermed står i forbindelse med dette. Selskapet kan delta i andre selskaper med lignende virksomhet, samt handle med aksjer og verdipapirer, herunder lånefinansierte investeringer med verdipapirer og valuta.
Address
Hvedings Gate 4, 9405 Harstad
Phone
+4792697053
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 403 | 6 508 | 5 763 | 4 877 | 4 369 |
| Staff expenses | −1 068 | −1 007 | −935 | −780 | −422 |
| EBITDA | 1 700 | 3 193 | 2 150 | 1 277 | 1 683 |
| Depreciation & amort. | −26 | −212 | −234 | −231 | −231 |
| EBIT | 1 673 | 2 982 | 1 917 | 1 046 | 1 452 |
| Net financials | −9 | −2 | 148 | 106 | 130 |
| Profit before tax | 1 664 | 2 980 | 2 064 | 1 153 | 1 582 |
| Tax | 370 | 658 | 448 | 251 | 376 |
| Net profit | 1 294 | 2 321 | 1 616 | 901 | 1 206 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 780 | 3 993 | 3 197 | 4 056 | 5 178 |
| Equity | 1 492 | 2 423 | 2 039 | 2 940 | 4 146 |
| Long-term debt | 0 | 3 | 0 | 0 | 0 |
| Short-term debt | 2 288 | 1 567 | 1 157 | 1 116 | 1 031 |
| Total debt | 2 288 | 1 570 | 1 157 | 1 116 | 1 031 |
EBITDA margin
38.5%
This company
15.8%
Market median
+144% vs market
20212025
Equity ratio
80.1%
This company
38.2%
Market median
+110% vs market
20212025
Return on equity
29.1%
This company
18.4%
Market median
+58% vs market
20212025
Net profit margin
27.6%
This company
8.1%
Market median
+241% vs market
20212025
Asset turnover
0.84×
This company
1.12×
Market median
+25% vs market
20212025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
TM Chief Executive Officer | Chief Executive Officer | 2006 |
HJ Deputy Member | Deputy Member | 2006 |
AM Deputy Member | Deputy Member | 2026 |
KS Deputy Member | Deputy Member | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LILJEN AS 
HUUBRO ASBoard members of LILJEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Turid Mikkelborg | Chief Executive Officer | 0 companies |
| Helge Jørger Sommerseth | Deputy Member | 0 companies |
| Ann-Helen Mikkelborg | Deputy Member | 0 companies |
| Kent-Ivar Sørnes | Deputy Member | 0 companies |
| Rolf Jensen | Board of Directors | 0 companies |
| Kjersti Mikkelborg | Board of Directors | 0 companies |